166 related articles for article (PubMed ID: 34461606)
21. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
[TBL] [Abstract][Full Text] [Related]
22. Histidine-rich glycoprotein augments natural killer cell function by modulating PD-1 expression via CLEC-1B.
Nishimura Y; Wake H; Teshigawara K; Wang D; Sakaguchi M; Otsuka F; Nishibori M
Pharmacol Res Perspect; 2019 Jun; 7(3):e00481. PubMed ID: 31143450
[TBL] [Abstract][Full Text] [Related]
23. Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer.
Tsumura R; Haruta M; Kuwano M; Yasunaga M
Sci Rep; 2023 Apr; 13(1):6803. PubMed ID: 37100864
[TBL] [Abstract][Full Text] [Related]
24. The expression of killer cell inhibitory receptors on natural killer cells and activation status of CD4+ and CD8+ T cells in the decidua of normal and abnormal early pregnancies.
Chao KH; Wu MY; Chen CD; Yang JH; Yang YS; Ho HN
Hum Immunol; 1999 Sep; 60(9):791-7. PubMed ID: 10527385
[TBL] [Abstract][Full Text] [Related]
25. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
Masuyama J; Murakami T; Iwamoto S; Fujita S
Cytotherapy; 2016 Jan; 18(1):80-90. PubMed ID: 26549384
[TBL] [Abstract][Full Text] [Related]
27. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
28. Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2.
Moltó L; Carballido J; Manzano L; Martinez-Martin B; Esquivel F; Chafer J; Olivier C; Alvarez-Mon M
J Immunother; 1999 May; 22(3):260-7. PubMed ID: 10335486
[TBL] [Abstract][Full Text] [Related]
29. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
[TBL] [Abstract][Full Text] [Related]
30. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
Bradstock KF; Luxford C; Grimsley PG
Immunol Cell Biol; 1993 Dec; 71 ( Pt 6)():535-42. PubMed ID: 7508887
[TBL] [Abstract][Full Text] [Related]
31. Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.
Bojarska-Junak A; Hus I; Sieklucka M; Wasik-Szczepanek E; Mazurkiewicz T; Polak P; Dmoszynska A; Rolinski J
Oncol Rep; 2010 Sep; 24(3):803-10. PubMed ID: 20664990
[TBL] [Abstract][Full Text] [Related]
32. Dysfunction of natural killer cells mediated by PD-1 and Tim-3 pathway in anaplastic thyroid cancer.
Yin M; Di G; Bian M
Int Immunopharmacol; 2018 Nov; 64():333-339. PubMed ID: 30243069
[TBL] [Abstract][Full Text] [Related]
33. Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer.
Oikawa T; Kawai K; Ishiwata I; Ohno T; Akaza H
BJU Int; 2003 Dec; 92(9):1009-15. PubMed ID: 14632866
[TBL] [Abstract][Full Text] [Related]
34. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
[TBL] [Abstract][Full Text] [Related]
36. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
37. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
38. Immunologic effects in patients with psoriatic arthritis treated with cyclosporine A.
Boiardi L; Salvarani C; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Lodi L; Portioli I
J Rheumatol; 1992 Dec; 19(12):1933-7. PubMed ID: 1284133
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.
Zupo S; Azzoni L; Massara R; D'Amato A; Perussia B; Ferrarini M
J Clin Immunol; 1993 May; 13(3):228-36. PubMed ID: 7686565
[TBL] [Abstract][Full Text] [Related]
40. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer.
Fernandez SV; MacFarlane AW; Jillab M; Arisi MF; Yearley J; Annamalai L; Gong Y; Cai KQ; Alpaugh RK; Cristofanilli M; Campbell KS
Breast Cancer Res; 2020 Dec; 22(1):134. PubMed ID: 33267869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]